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Effects of cooler temperature dialysate on hemodynamic stabifity in
"problem" dialysis patients. Symptomatic hypotension is a common
and disabling complication of hemodialysis treatments. The incidence
of symptomatic hypotensive episodes is particularly high in patients
who have normal or low blood pressure at the initiation of dialysis and
in patients who have large interdialytic weight gains. The aim of this
study was to determine whether cooling the dialysate temperature from
37°C to 35°C improved tolerance to dialysis in a group of 12 of these
"problem" patients. A double-blinded protocol was performed in six
hypotension-prone and six large weight gainers who were subjected to
two identical hemodialyses except for the dialysate temperature of 37°C
or 35°C. Changes in biochemical parameters and weight were compa-
rable during the two maneuvers. Recumbent blood pressure declined
significantly (P < 0.01) during 37°C dialysis but not 35°C dialysis; blood
pressure was significantly lower at 1, 2, and 3 hours of 37°C dialysis
compared to 35°C dialysis (P < 0.05). Further, both supine and upright
blood pressure was significantly lower following 37°C dialysis (P <
0.02). This lower blood pressure was present in both subgroups of
patients. All 18 episodes of symptomatic hypotension noted during the
study occurred during 37°C dialysis. A significantly greater increase in
peripheral vascular resistance (calf blood flow was measured directly by
venous occlusion plethysmography) occurred upon exposure to the
35°C dialysate in both subgroups of patients (P < 0.01); supine and
upright post-dialysis plasma norepinephrine values were also signifi-
cantly greater (P < 0.001) after 35° dialysis. Thus, 35°C dialysate
significantly improves the hemodynamic tolerance to hemodialysis in
hypotension-prone and large weight gainer patient groups and also
reduces the incidence of symptomatic hypotension. This improvement
is partly the result of a greater increase in peripheral vascular resis-
tance, possibly mediated via the efferent sympathetic nervous system.
It is estimated that between 20 and 30% of hemodialysis
treatments are complicated by symptomatic hypotensive epi-
sodes [1, 2]. The etiology of these hypotensive episodes is
multifactorial: factors such as poor cardiac reserve [3], auto-
nomic neuropathy [4, 5], and a decline in plasma osmolality [6]
have all been implicated as important in causing this complica-
tion. In addition, a recent study from our institution suggested
that a reflex decline in sympathetic nervous system-mediated
vasoconstriction may also play a role in sudden hypotension in
patients [7]. Recent interest has been focused on the possibility
that cooling the dialysate temperature from 37°C to 35°C affords
a stabilizing effect on systemic hemodynamics during ultrafil-
tration dialysis [8—17]. Particularly notable among these earlier
studies are the observations of Sherman et al [13], who found
that a reduction in the dialysis bath temperature from 37°C to
35°C resulted in a significant decrease in the frequency of
episodic symptomatic hypotension and to greater stability of
blood pressure during the entire dialytic session. In addition,
two previous studies had noted an increase in calculated total
peripheral vascular resistance and a rise in plasma cate-
cholamine concentrations in response to cooler temperature
dialysate [9, 17]. Finally, our group recently showed that cooler
temperature dialysate also improves left ventricular contractil-
ity independently of preload and afterload [18].
Despite these studies showing the improved stability of blood
pressure in "some" dialysis subjects, prior studies have not
addressed the ability of the cooling maneuver to improve
hemodynamics in "exclusively problem" hemodialysis pa-
tients. Moreover, a direct measurement of peripheral vascular
resistance has not been previously attempted in such a popula-
tion of patients. Additionally, orthostatic blood pressure
changes before and after dialysis have also not been previously
performed in such patients. Accordingly, we performed the
present studies to determine the ability of cooler temperature
dialysate to improve hemodynamics in two groups of patients in
whom ultrafiltration during dialysis is often problematic. One
patient group is normotensive or actually hypotensive at the
beginning of hemodialysis and experiences frequent bouts of
episodic hypotension during the ultrafiltration procedure. A
second group of patients is characterized by large interdialytic
weight gains with resultant greater ultrafiltration requirements,
and, as a consequence, they experience orthostatic hypoten-
sion, particularly at the conclusion of dialysis. We specifically
wanted to know whether cooler temperature dialysate was of
therapeutic benefit in these more tenuous patients, and whether
or not the mechanism of any protection afforded by cooler
temperature dialysis was mediated through an effect on periph-
eral vasculature.
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Methods
Patient population
A total of 12 male hemodialysis patients ranging in age from
37 to 79 years (mean 62.5 3.6 years) who had been on
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hemodialysis from 3 to 72 months (mean 35.4 6.2) volun-
teered for this study. The protocol was approved by the Human
Studies Subcommittee of the Department of Veterans Affairs
Medical Center, and informed consent was obtained from each
subject. The patients were selected from a chronic dialysis
population of 60 patients and placed into one of two groups
because they met the criteria for patient study. One group
(hypotension-prone, N = 6)was characterized by normotension
or hypotension pre-hemodialysis (mean blood pressure 90
mm Hg); these patients also were characterized by the fact that
symptomatic hypotension (systolic blood pressure < 90 mm
Hg, the requirement for volume expansion therapy, or symp-
toms such as nausea, cramping, or vomiting) occurred in 30% or
more of dialysis encounters. The second group of patients
(weight gainers, N = 6) was selected because they consistently
gained > 4 kg (about 5% of body weight) in the interdialytic
period. These patients also had hemodynamic instability, al-
though this was usually manifest upon standing at the conclu-
sion of dialysis. This second group of patients was character-
ized by a  20 mm Hg fall in mean blood pressure upon standing
at the conclusion of hemodialysis in at least 25% of their prior
dialyses. The etiology of renal failure in the patients selected for
this study included hypertension in seven subjects, nephrolithi-
asis in 1 patient, glomerulonephritis in two patients and diabetes
mellitus in two patients. Seven patients were taking antihyper-
tensive medicines; these were held on the day of hemodialysis.
Routine medications included phosphate binders, antipruritics,
and sodium bicarbonate. None of the patients were taking
13-adrenergic blockers.
Experimental protocol
A double-blind, cross-over study design was used. Each
patient underwent two dialyses, exactly one week apart, con-
sisting of exposure to either 37°C or 35°C dialysate. The dialysis
procedures were performed in random order with both the
patient and the investigators blinded. All patients were clini-
cally stable during this time, with no changes in medications or
their usual clinical circumstances. During each maneuver, the
ultrafiltration goal was set to achieve the patient's target "dry"
weight.
Hemodialysis was performed using a Fresenius F8 dialyzer
(Fresenius USA Inc., Concord, California, USA). This dialyzer
has a surface area of 1.80 m2, an ultrafiltration coefficient of 8.1
mllhr/mm Hg and is composed of polysulfone fibers. Dialyzers
were not reused during the study. A Frensenius model 2008 E
dialysis machine (Fresenius) was utilized for each procedure.
Dialysate temperature was constantly monitored throughout
the course of dialysis using an in-line thermometer. Dialysate
flow rates were set at 500 mllmin. Blood flow rates were the
usual prescription for each individual and ranged from 350 to
450 mllmin. The dialysis parameters were identical from patient
to patient and week to week. A constant ultrafiltration rate was
maintained throughout the procedure. The dialysate consisted
of the following constituents: sodium (140 mmollliter), potas-
sium (2 or 3 mmollliter), chloride (110 mmol/liter), bicarbonate
(30 mmollliter), glucose (11.1 mmollliter), calcium (1.75 mmoll
liter). The individual patient's dialysate was also identical in
both experimental maneuvers.
Weights were obtained pre- and post-dialysis using the same
balanced scale. Oral temperature was also obtained pre- and
post-dialysis using a digital thermometer. Upon arrival to the
dialysis unit and after being weighed, the patient was placed in
a semi-recumbent position, and needles for hemodialysis placed
as per routine. After five minutes in this position, baseline blood
samples were obtained for pre-hemodialysis electrolytes and for
supine catecholamines. Catecholamine samples were collected
in heparinized tubes and immediately placed in ice, centrifuged,
and frozen at —70°C until assayed. Blood pressure and heart
rate were then recorded, and the patient was allowed to stand
for three minutes, whereupon blood pressure and heart rate
were again measured and a standing plasma catecholamine
sample was obtained. The patient then remained semi-recum-
bent for the remainder of the dialysis procedure. These ortho-
static blood pressure tests and plasma catecholamines were
repeated in an identical fashion at the conclusion of hemodial-
ysis. Mean blood pressure was calculated from the formula
(Systolic blood pressure — Diastolic blood pressure) ÷ 3 +
Diastolic blood pressure. Electrolytes, blood urea nitrogen,
creatinine, and calcium were measured using a SMAC II
analyzer (Teknicon Instruments Corporation, Terrytown, New
York, USA) in the regular hospital laboratory. Hematocrit was
measured on a Colter Counter (Colter Electronics Inc., Hi-
aleah, Florida, USA). Plasma norepinephrine values were mea-
sured using a radioenzymatic technique in a commercial labo-
ratory (Smith, Kline and Beecham Clinical Laboratories,
Dallas, Texas, USA). The normal supine norepinephrine value
in this laboratory is 110 to 410 pg/mi. Blood pressure and heart
rate were continuously recorded during the dialysis procedure
using an automatic blood pressure recorder connected to the
dialysis machine. In addition, any episodes of symptomatic
hypotension requiring therapy were also continuously moni-
tored and recorded. Direct measurements of peripheral resis-
tance were performed as detailed below.
Calf blood flow and venous occlusion plethysmography
Regional blood flow was directly measured with the tech-
nique of venous occlusion plethysmography [19]. Measure-
ments of calf blood flow were obtained prior to the start of
hemodialysis ("0" time), and at one hour, two hours, and three
hours (finish). To perform direct measurements of regional
blood flow, calf blood flow was measured by elevating the calf
above the level of the right atrium to collapse the veins. The
circulation to the foot was arrested during the blood flow
determinations, which were performed during 15 second inter-
vals. Call vascular resistance was calculated as the mean
arterial pressure in mm Hg divided by calf blood flow in ml per
mm per 100 ml of tissue.
Statistics
Comparisons of biomedical data, mean arterial pressures,
heart rates, and peripheral vascular resistances were performed
by repeated measures analysis of variance with a P < 0.05
considered significant. Data are expressed as the mean 1 SEM.
Results
Changes in biochemical parameters and weights during 37°C
and 35°C hemodialyses
Exposure to 35°C dialysate lowered body temperature a mean
of 0.42°C (P < 0.005); during 37°C dialysis, body temperature
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Table I. Biochemical parameters pre- and post-hemodialysis
(N = 12)
37° 35°
Pre Post Pre Post
Sodium
mmol/liter 139 1.1 139.2 1.3 138.2 0.8 138 0.7
Potassium
mmol/liter 4.9 0,2 3.5 0.Ola 4.8 0.2 3.6 0.1°
Chloride
mmol/liter 97.2 1.3 98.2 1.3 96.5 1 96.1 1.1
Bicarbonate
mmol/liter 20.5 1 25.6 0.9° 21.4 1.1 26.8 ia
Creatinine
mg/dl 11.9 1 5.4 7° 12.4 1.2 5.6 6°
p,nol/liter 1056 88.7 479 62.1 1100 106.4 496.7 53.2
BUN
mg/dl 61.4 6.8 24.4 3.2° 57.8 4 23 2.3°
p.nol/liter 21.8 2.4 8.7 1.1 20.5 1.4 8.2 0.86
Calcium
mg/dl 8.98 39 8.90 0.18 9.08 0.3 9.02 0.16
p.mol/lizer 2.2 0.09 2.2 0.04 2.2 0.07 2.2 0.03
Hematocrit
% 26.4 1.6 27.6 1.4 28.8 1.6 30.1 1.6
Pre-dialysis and post-dialysis values were not different between 37°C
and 35°C dialysis treatments.
Different from pre-hemodialysis value, P < 0.001
increased 0.11°C (NS). As expected, changes in biochemical
parameters were similar in 37°C and 35°C dialyses for all 12
patients (Table 1). Comparable and significant decrements in
potassium, BUN, and creatinine occurred in both maneuvers.
When the biochemical data were analyzed in the two subgroups
of patients, similar changes were again observed when compar-
ing pre- to post-hemodialysis values. The only biochemical
difference between the two patient subgroups was that the
pre-dialysis creatinine was significantly lower (P < 0.005) in the
hypotension-prone group (9.5 .3 mg/dl) versus the weight
gainer group (15.3 .7 mg/dl) for both 37°C and 35°C dialyses.
Post-dialysis creatinine values were comparable in the two
sub-groups following both procedures. The Ks/V for the hypo-
tension-prone group was 1.11 .05 and for the weight gainer
group 1.24 0.06 (NS).
Baseline weights were comparable in the two procedures, as
were post-dialysis weights, the amount of weight lost, and the
percentage of weight lost (Table 2). Table 2 also shows the
changes in weight for both the hypotension-prone as well as
large weight gain sub-groups. As expected, weight loss and
percent of weight loss were greater in the latter group of
patients, however, weight losses were comparable during 37°
and 35° hemodialyses within each subgroup.
Effects of 37°C and 35°C hemodialysis on blood pressure
Figure 1 depicts the changes in recumbent mean blood
pressure for all patients during both dialysis procedures. Base-
line MBP was comparable at the start of dialysis, however,
during 37°C dialysis, recumbent MBP declined a mean of 12 mm
Hg, from 96 16 mm Hg to 84 15 mm Hg (P < 0.01). In
contrast, MBP was well maintained throughout 35°C dialysis,
decreasing from 102 23 to 96 19 mm Hg (NS). Moreover,
when all 12 patients were analyzed, the recumbent MBP was
significantly lower in 37°C versus 35°C dialysis at one, two and
three hours (P <0.05; Fig. 1). This pattern of greater recumbent
MBP during 35°C dialysis was true for both the hypotension-
prone and weight gainer patient subgroups.
Two additional analyses of MBP were done. First, when all
12 patients were analyzed, both supine and upright MBP were
significantly lower after 37°C dialysis compared to 35°C dialysis
(Fig. 2). Second, when the patients were divided into the two
subgroups, 35°C dialysis was also noted to afford greater
hemodynamic stability post-dialysis. During 37°C dialysis, su-
pine to upright MBP fell significantly in both hypotension-prone
(P < 0.05) and weight gainer patients (P <0.05). In contrast,
following the 35°C procedure, supine to upright MBP was stable
in the hypotension-prone patients (84 6 to 85 5 mm Hg).
The orthostatic MBP changes in weight gainers were character-
ized by a significant fall after both 37°C (98 6 to 91 10 mm
Hg, P < 0.05) and 35°C (108 4 to 99 6.2 mm Hg, P < 0.05)
dialyses. However, although there was a significant orthostatic
fall in MBP after 35°C dialysis in this subgroup, the supine and
standing MBP's after 35°C dialysis were greater than after 37°C
dialysis.
Episodes of symptomatic hypotension on 37°C and 35°C
hemodialysis
A total of 18 episodes of symptomatic hypotension requiring
treatment with volume for a systolic BP 90 mm Hg were
observed during the dialysis procedures. Of these, a total of 16
occurred in the hypotension-prone group of patients. Further,
all 18 of the episodes occurred during 37°C hemodialysis.
Hence, there were no episodes of symptomatic hypotension
during the 35°C hemodialysis treatments (P < 0.01 by McNe-
mar test of probabilities, 35°C vs. 37°C).
Effects of 37°C and 35°C hemodialysis on calf blood flow and
peripheral vascular resistance (PVR)
To examine the mechanism of hemodynamic stability af-
forded by 35°C dialysis in both groups of patients, PVR was
directly assessed by measuring calf blood flow with venous
occlusion plethysmography. As shown in Figure 3a, PVR
increased significantly during 37°C dialysis. However, the in-
crease in PYR was significantly greater during 35°C dialysis at
one, two and three hours. Figure 3b shows this pattern of a
greater increase in PVR during 35°C dialysis held for both
hypotension-prone and weight gainer subgroups.
Effects of 37°C and 35°C hemodialysis on supine and upright
plasma norepinephrine values
As shown in Figure 4, in both 37°C and 35°C dialyses, supine
to upright plasma norepinephrine concentrations increased sig-
nificantly post-dialysis. Of note is the fact that 35°C dialysis
caused a significantly greater increase in upright plasma norepi-
nephrine values post-dialysis compared to 37°C dialysis (1290
143 vs. 830 130 pglml, P <0.02).
Norepinephrine values in hypotension-prone and large
weight gainers are shown in Table 3. As can be seen, this
pattern of a significantly greater increase in post-dialysis nor-
epinephrine values following 35°C dialysis was present in both
subgroups of patients. In the weight gainer group, both supine
and upright plasma norepinephrine values were greater after
Pro-dialysis Post-diaJvss
75
5o
SUE UEB
P<O.02 PcO.02
125
SUE UER
NS NS
I
25 L
a Significantly less than pre-hemodialysis, P < 0.005b Significantly less than weight gainers, P < 0.01
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Table 2. Weight changes during 37° and 35° hemodialyses
Fig. 1. Changes in recumbent MBPfor all patients during both dialysis
procedures are shown. Symbols are: (E) 35°; (•) 37°. Baseline MBP's
were comparable; during 37°C dialysis, MBP declined from 96 16 to
84 15 mm Hg (P < 0.01). MBP was well-maintained during 35°C
dialysis. p < 0.05, 37°C dialysis vs. 35°C dialysis.
35°C dialysis compared to 37°C dialysis. In the hypotension-
prone group, post-dialysis upright norepinephrine levels were
significantly greater after 35°C dialysis (P < 0.02); supine
post-dialysis norepinephrine values were of borderline signifi-
cance in this patient group (P < 0.10 > 0.05).
Discussion
Symptomatic hypotension during dialysis remains a disabling
and vexing problem, and contributes to the overall morbidity
associated with the hemodialysis procedure. Thus, maneuvers
that improve the hemodynamic stability of patients during
ultrafiltration hemodialysis have been aggressively sought in the
past decade. Although several maneuvers have been developed
that improve systemic hemodynamics, these are often not
tested in groups of patients in whom the risk for symptomatic
hypotension is greatest. Therefore, in this study we systemati-
cally examined the ability of cooling the dialysate temperature
to affect systemic hemodynamics during ultrafiltration dialysis
in two groups of patients with a predisposition to symptomatic
hypotension. One group of patients is generally characterized
by a low or normal blood pressure pre-dialysis. This group of
patients is at risk for hypotension because the margin for blood
pressure reduction during the ultrafiltration procedure is ex-
ceedingly low. This group of hypotension-prone patients is
Fig. 2. Changes in supine (SUP) and upright (UPR) MBP pre- and
post-dialysis are shown for all patients. Pre-dialysis MBP's were similar
in both positions. Symbols are: (0) 37°; () 35°. After 37°C dialysis,
both supine and upright MBP was lower (P < 0.02).
characterized by many years on hemodialysis, high circulating
angiotensin II levels, and decreased angiotensin receptor bind-
ing to platelets [20]. The second group of patients were those
patients characterized by large interdialytic weight gains. These
patients are vulnerable to hypotension because they are re-
quired to lose an extraordinary amount of weight during a short
time, and therefore are often unstable when they assume the
upright position post-dialysis. Another goal of the study was to
examine the effects of cooler temperature dialysis on directly
measured peripheral vascular resistance in both of these sub-
groups of "problem" hemodialysis patients.
As is apparent from the results, the 35°C dialysate tempera-
ture was associated with improved blood pressure stability in
both subgroups of "problem" patients. Although blood pres-
sure declined significantly in both subgroups of patients during
the ultrafiltration procedure, a greater fall in blood pressure was
observed throughout the course of 37°C dialysis as compared to
35°C dialysis. Moreover, when patients had completed the
dialysis procedure and assumed the upright posture, a signifi-
cant fall in blood pressure occurred in both groups of patients
following 37°C dialysis. In contrast, assumption of the upright
37° 35°
Pre Post Pre Post
For all 12 patients 77.6 5.4 74.4 5.2a 77.1 5.6 74.1 5.4
%Change 4.1% 4.2%
For 6 hypotension-prone patients 66.4 s3b 64 49a.b 65.3 42b 63.3 5a,b
% Change 3%b 31%b
For 6 weight gainers 88.8 5.1 84.3 7•3a 88.9 7.1 84.6 74a
%Change 5.1% 5.1%
E
110
100
90
*80
0'
0 lhr 2hr 3hr
Dialysis time
Pre-hemodialysis Post-hemodialysis
370 350 370 350
1200
1100
1000
800
a.70o60O50o
0-
• .. •. _
NS <0.01 <0.001 <0.001
NS
<0.02
Fig. 3A. Changes in ca/f vascular resistance (CVR, units) are shown for all patients. Symbols are: (Li) 35°; (U) 37°. CVR increased moderately
in patients during 37°C dialysis. However, a more dramatic increase in PVR was observed during the 35°C dialysis at I, 2, and 3 hr. B. The pattern
in changes in CVR noted in 3a held in both subgroups of patients as CVR increased more during 35°C dialysis. Symbols are for 35°C vs. 37°C
dialysis: (Li) weight gainers 37°C; (U) weight gainers 35°C; (A) hypotension-prone 37°C; (A) hypotension-prone 35°C. < 0.01 35°C vs. 35°C
dialysis at 1, 2, and 3 hr.
posture following 35°C dialysis was not associated with a
significant fall in blood pressure in the hypotension-prone group
and a higher upright blood pressure in the weight gainer group.
In support of this hemodynamic stability that was observed in
both recumbent and upright positions throughout and following
dialysis, the frequency of symptomatic hypotension observed in
the two procedures was strikingly different. Of 18 episodes
requiring treatment with volume-expansion therapy for a sys-
tolic blood pressure 90 mm Hg, none occurred during 35°C
dialysis. As might be expected, 16 of the 18 episodes occurred
in the group of patients characterized as "hypotension-prone".
Hence, 35°C dialysis not only provided improved blood pres-
sure control during the entire dialysis procedure, it was also
associated with strikingly less symptomatic hypotension during
the course of the procedure and an ability to maintain hemody-
namic stability upon the assumption of the upright posture
post-hemodialysis. These observations are even more impres-
sive when one considers the fact that the subgroups of patients
studied in these set of experiments were particularly vulnerable
to the hypotensive effects of ultrafiltration hemodialysis,
The data also address the mechanisms by which 35°C dialysis
afford hemodynamic stability. Direct measurements of calf
blood flow were performed to allow a more direct measure of
peripheral vascular resistance. Congruent with the improved
stability of blood pressure during the 35°C hemodialysis, a
Fig. 4. Changes in plasma norepinephrine (NE) values are shown for
all 12 patients. Supine (Li) to upright (Li) NE levels increased signifi-
cantly post-HD in both 37°C and 35°C dialysis (P < 0.001). However,
the upright NE level post-HD was significantly greater following 35°C
dialysis (P < 0.02).
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Table 3. Supine and upright plasma norepinephrine values (pg/ml) in hypotension-prone and large weight gainers
37° 35°
Pre
Sup Upr
Post
Sup Upr
Pre
Sup Upr
Post
Sup Upr
Hypotension-prone
722
SE 146
Weight gainers
881
SE 256
897
228
1035
348
534
125
582
130
729
136
93Ø
228
771
150
744
227
975
261
948
276
767
121
879°
154
l248
252
1332a,b
139
a Greater than supine NE value, P < 0.025
b Greater than 37°C post-dialysis upright NE, P <0.02
Greater than 37°C post-dialysis supine NE value, P < 0.02
strikingly greater increase in calf vascular resistance was ob-
served during exposure to 35°C dialysate as compared to 37°C
dialysate. It should be stressed that calf vascular resistance
during the 37°C dialysate exposure increased steadily during the
course of the dialysis. However, as early as one hour into the
dialysis, calf vascular resistance was greater and calf blood flow
was less in the 35°C dialysis exposures. This difference was
maintained and actually increased at both the two hour and
three hour time of dialysis. Surprisingly, none of the patients
complained of being chilled or cramping during the 35°C dialy-
sis. Although 35°C dialysate could conceivably cause discom-
fort (by leading to excessive vasoconstriction and ischemia) in
patients with marginal peripheral circulations, all of our patients
tolerated the procedure very well.
The mechanism for the increase in peripheral vascular resis-
tance is also partially addressed by these studies. Although
there may not be a tight correlation between efferent sympa-
thetic nervous system outflow and plasma norepinephrine in all
cases (and particularly in the 37°C dialyses) [21], in the present
study plasma norepinephrine levels mirrored the changes in
peripheral vascular resistance. In the 35°C exposures, there was
a greater increase in both supine and upright plasma norepi-
nephrine levels following ultrafiltration dialysis as compared to
the 37°C dialysis exposures. Thus, efferent sympathetic outflow
would appear to have been increased by exposure to 35°C
dialysate. Since the cold pressor test is known to increase
sympathetic vasoconstrictive outflow [22], it is quite possible
that total body cooling by 0.3 to 0.5°C causes a similar reaction.
In our earlier study of the effects of cooler temperature dialy-
sate on left ventricular function [18], we were unable to show an
effect of cooler temperature dialysis on plasma norepinephrine
values. However, in that study, a smaller number of patients (N
= 6) was used, and one patient deviated significantly from the
overall trend. Also in agreement with the present observation
are the previous studies of Mahida et al [16] who noted an
increase in supine norepinephrine levels that was greater in
35°C hemodialysis vs 37°C dialysis. A final potential mechanism
whereby 35°C could improve blood pressure and increase
peripheral vascular resistance is by reducing the production of
interleukins, tumor necrosis factor and possibly nitric oxide [23,
24]. While the roles of these mediators in dialysis hypotension
await definitive studies, it is at least conceivable that cooler
temperature dialysis decreases production of these substances.
The results of this study support a trial of cooler temperature
dialysis in patients with a proclivity to dialysis hypotension.
The mechanism of improved blood pressure maintenance would
appear to be twofold: first, an increase in peripheral vascular
resistance, presumably as a result of an increase in efferent
sympathetic outflow appears to occur. Second, the maneuver is
also associated with an increase in cardiac contractility [18],
possibly secondary to the increase in catecholamines. The sum
of these two effects significantly improves the ability to achieve
goal ultrafiltration requirements during the hemodialysis en-
counter while avoiding the disabling consequences of symptom-
atic hypotension. Although the etiology of dialysis hypotension
remains multifactorial, the use of cooler temperature dialysate
appears to offer a practical therapeutic benefit, even in "prob-
lem" dialysis subjects.
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